A promoter genotype and oxidative stress potentially link resistin to human insulin resistance

被引:139
作者
Smith, SR [1 ]
Bai, FL [1 ]
Charbonneau, C [1 ]
Janderová, L [1 ]
Argyropoulos, G [1 ]
机构
[1] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
关键词
D O I
10.2337/diabetes.52.7.1611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin resistance is a component of type 2 diabetes and often precedes pancreatic beta-cell failure. Contributing factors include obesity and a central pattern of fat accumulation with a strong genetic component. The adipocyte secreted hormone resistin has been proposed as a link between the adipocyte and insulin resistance by inhibition of insulin-stimulated glucose uptake and/or blocking adipocyte differentiation. Here we report that the G/G genotype of a single nucleotide polymorphism (SNP) in the promoter of the human resistin gene, -180C>G, had significantly increased basal promoter activity in adipocytes. These data were recapitulated in vivo, where G/G homozygotes had significantly higher resistin mRNA levels in human abdominal subcutaneous fat. A significant interaction was also found between the -180C>G SNP, a marker of oxidative stress (NAD[P]H quinone oxidoreductase mRNA) and homeostasis model assessment of insulin resistance. In addition, resistin mRNA was positively and independently correlated with insulin resistance and hepatic fat as measured by liver X-ray attenuation. These data implicate resistin in the pathophysiology of the human insulin resistance syndrome, an effect mediated by the -180C>G promoter SNP and potentially cellular oxidative stress.
引用
收藏
页码:1611 / 1618
页数:8
相关论文
共 41 条
[11]   Regulation of genes encoding NAD(P)H:quinone oxidoreductases [J].
Jaiswal, AK .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (3-4) :254-262
[12]  
Jonke J, 2002, OBES RES, V10, P1
[13]   The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on oxidative enzymes in adipocytes and liver [J].
Kern, PA ;
Fishman, RB ;
Song, W ;
Brown, AD ;
Fonseca, V .
TOXICOLOGY, 2002, 171 (2-3) :117-125
[14]   Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and β-arrestins [J].
Kim, KM ;
Valenzano, KJ ;
Robinson, SR ;
Yao, WD ;
Barak, LS ;
Caron, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (40) :37409-37414
[15]  
Le Lay S, 2001, BIOCHEM BIOPH RES CO, V289, P564, DOI 10.1006/bbrc.2001.6015
[16]   Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians [J].
Ma, XW ;
Warram, JH ;
Trischitta, V ;
Doria, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (09) :4407-4410
[17]   HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN [J].
MATTHEWS, DR ;
HOSKER, JP ;
RUDENSKI, AS ;
NAYLOR, BA ;
TREACHER, DF ;
TURNER, RC .
DIABETOLOGIA, 1985, 28 (07) :412-419
[18]   A role for the Agouti-Related Protein promoter in obesity and type 2 diabetes [J].
Mayfield, DK ;
Brown, AM ;
Page, GP ;
Garvey, WT ;
Shriver, MD ;
Argyropoulos, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (02) :568-573
[19]   Resistin, central obesity, and type 2 diabetes [J].
McTernan, CL ;
McTernan, PG ;
Harte, AL ;
Levick, PL ;
Barnett, AH ;
Kumar, S .
LANCET, 2002, 359 (9300) :46-47
[20]  
Morin N, 2001, J PHARMACOL EXP THER, V297, P563